I see no value in a T/O for us Ear shareholders. NTS is fully priced. I would prefer to see Ear become a producer and see the share price go above $.60 in 12 months.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025